EdgarLookup
10-K XBRL

10-K Filing

Company
ABVC BIOPHARMA, INC.
Filed
April 16, 2015
Period of Report
September 30, 2013
Accession Number
0001557234-15-000092

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →